Home Page  
    Advanced
Search
Home Page Corporate Services Careers Specialties Strategic Alliances Events & Speakers Investigators Study Volunteers Contact

  All Services

>Preclinical

      Strategic Development

    >Preclinical Evaluation

          AAALAC Accredited

          Human Tumor
          Xenografts

          Angiogenesis Models

          Radioactivity

          In Vitro and Biomarker
          Capabilities

        >Acute Toxicity and PK

          Hematology Analysis

          Corneal Micropocket
          Assay

          Cachexia Model

          Intratibial Tumor Model

          Neurotoxicity Model

          Orthotopic Models

      CMC Consulting

      Pharm/Tox Consulting

      Regulatory Submissions

  Phase I

  Phase II-IIIb

  Post-Approval

  Labs

Acute Toxicity and Pharmacokinetics

Bioavailability and acute toxicology evaluation are critical components of early preclinical drug development. Piedmont Research Center offers basic services in bioavailability, pharmacokinetics and toxicity analysis. All studies are conducted in the spirit of GLP. GLP toxicology studies are available onsite through collaboration with Biotechnics, Inc.

Toxicology studies can include any or all of the following:

  • Timed dosing and sampling
  • Tissue and/or organ preservation
  • Plasma and/or serum sampling
  • Radiolabeled compounds
  • Histology and pathology
  • CBC with differentials
  • Chem CS
  • GLP monitoring

Pharmacokinetic sampling can be designed as a stand alone one- to thirty-day study, or it can be incorporated into your efficacy protocol.

PPD Preclinical Services